05:39 PM EDT, 06/03/2024 (MT Newswires) -- Royalty Pharma ( RPRX ) said Monday it priced an offering of $1.5 billion of senior unsecured notes, which is expected to close on June 10.

The company is offering $500 million of 5.150% notes due 2029, $500 million of 5.400% notes due 2034, and $500 million of 5.900% notes due 2054.

Net proceeds will be used for general corporate purposes, it said.